BiotechTube
Home/PAM Theragnostics/Michaela Press
MP

Michaela Press

R&D Scientist

PAM Theragnostics

Therapeutic Areas

Alzheimer's Disease

PAM Theragnostics Pipeline

DrugIndicationPhase
PAM TherapyAlzheimer's DiseasePre-clinical

Leadership Team at PAM Theragnostics

AB
Andreas Bergmann
Chief Executive Officer
PK
Paul Kaufmann
Head of Operations
YI
Yulia Ilina
Chief Scientific Officer
View full PAM Theragnostics profile